Publications found:
400
Sort by:
Global Stem Cell Therapy Market - Forecast from 2026 to 2031
US$ 3,950.00
Global Stem Cell Therapy Market, with a 17.81% CAGR, is projected to increase from USD 392.506 million in 2025 to USD 1049.353 million in 2031. The stem cell therapy market is a high-potential segment...
January 2026
145 pages
Global Cytokines Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... display the global Cytokines market. Chapter 1, to describe Cytokines Introduction, product scope, market overview, market opportunities, market risk, market driving force; Chapter 2, to analyze the top manufacturers of Cytokines, with sales ...
January 2026
95 pages
The 2027-2032 World Outlook for Antibody Drugs
US$ 1,195.00
This study covers the world outlook for antibody drugs across more than 190 ... not discuss the specific players in the market serving the latent demand, nor specific details ... the P.I.E., for antibody drugs. It also shows how the P.I.E. is divided across the world's regional and national markets. For each country ...
January 2026
288 pages
The 2027-2032 World Outlook for Biobanking Media
US$ 1,195.00
This study covers the world outlook for biobanking media across more than 190 countries. For each year ... . This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product ...
January 2026
287 pages
The 2027-2032 World Outlook for Colorectal Cancer Monoclonal Antibodies (mAb)
US$ 1,195.00
This study covers the world outlook for colorectal cancer monoclonal antibodies (mAb) across more than 190 countries. For each ... demand, or the P.I.E., for colorectal cancer monoclonal antibodies (mAb). It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I ...
January 2026
297 pages
The 2027-2032 World Outlook for Esophageal Cancer Monoclonal Antibodies (mAb)
US$ 1,195.00
This study covers the world outlook for esophageal cancer monoclonal antibodies (mAb) across more than 190 countries. For each ... demand, or the P.I.E., for esophageal cancer monoclonal antibodies (mAb). It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I ...
January 2026
299 pages
The 2027-2032 World Outlook for Gastric Cancer Monoclonal Antibodies (mAb)
US$ 1,195.00
This study covers the world outlook for gastric cancer monoclonal antibodies (mAb) across more than 190 countries. For each year ... demand, or the P.I.E., for gastric cancer monoclonal antibodies (mAb). It also shows how the P.I.E. is divided across the world's regional and national markets. For each country, I ...
January 2026
293 pages
Global Plasminogen Market 2026 by Company, Regions, Type and Application, Forecast to 2032
US$ 3,480.00
... from 11400 million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Plasminogen in global market, especially in North America, ... growth rate by type, application, from 2014 to 2019. Chapter 12, Plasminogen market forecast, by regions, type and application, with sales ...
January 2026
62 pages
The 2027-2032 World Outlook for Anti-Graffiti Coatings
US$ 1,195.00
This study covers the world outlook for anti-graffiti coatings across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E....
January 2026
287 pages
The 2027-2032 World Outlook for Anti-Inflammatory Biologics
US$ 1,195.00
This study covers the world outlook for anti-inflammatory biologics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P...
January 2026
288 pages
The 2027-2032 World Outlook for Bioelectric Medicines
US$ 1,195.00
This study covers the world outlook for bioelectric medicines across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.)...
January 2026
287 pages
The 2027-2032 World Outlook for Biological Implants
US$ 1,195.00
This study covers the world outlook for biological implants across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.),...
January 2026
287 pages
The 2027-2032 World Outlook for Biologicals
US$ 1,195.00
This study covers the world outlook for biologicals across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the...
January 2026
289 pages
The 2027-2032 World Outlook for HER2 Antibodies
US$ 1,195.00
This study covers the world outlook for HER2 antibodies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for...
January 2026
287 pages
Global Cytokines Supply, Demand and Key Producers, 2026-2032
US$ 4,480.00
The global Cytokines market size is expected to reach $ 930200 million by 2032, rising at a market growth of 16.0% CAGR during the forecast period (2026-2032). Cytokines are a large group of small sig...
January 2026
111 pages
Cell Therapy Raw Materials Market Size, Share & Trends Analysis Report, By Product (Media, Sera, Antibodies, Reagents & Buffers), By End Use (CROs & CMOs, Biopharmaceutical & Pharmaceutical Companies), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global cell therapy raw materials market size was estimated at USD 5.47 billion in 2025 and is projected to reach USD 21.88 billion by 2033, growing at a CAGR of 19.15% from 2026 to 2033. Innovat...
December 2025
150 pages
Natural Albumin Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Source (Human Serum Albumin, Bovine Serum Albumin, and Plant Serum Albumin), Application (Therapeutic Applications, Drug Delivery, Disease Diagnostics, Research, and Others Applications), and End User (Hospitals and Clinics, Pharmaceutical and Biotechnological Companies, Research Institutes, Diagnostic Laboratories, Homecare Settings, and Others)
US$ 4,450.00
According to our new research study on “Natural Albumin Market Forecast to 2031 –Global Analysis – by Source, Application, and End User,” the market is anticipated to grow from US$ 5.66 billion in 202...
December 2025
236 pages
Automated And Closed Cell Therapy Processing Systems Market Size, Share & Trends Analysis Report By Workflow (Separation, Expansion, Apheresis), By Type (Stem Cell Therapy), By Scale (Commercial Scale), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global automated and closed cell therapy processing systems market size was estimated at USD 1.67 billion in 2025 and is projected to reach USD 7.44 billion by 2033, growing at a CAGR of 20.73% f...
December 2025
130 pages
Asia Pacific Cell and Gene Therapy Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type [Cell Therapy (Allogeneic, Autologous, Viral Vectors), and Gene Therapy (Non-viral Vectors and Viral Vectors]), Service (Process Development, cGMP Manufacturing, Regulatory Services, and Bioassay Services), Scale (Pre-commercial or R&D Manufacturing and Commercial Scale Manufacturing), Service Providers (CDMOs and CMOs), Transfection Reagents (Polymer-based Transfection Reagents, Lipid-based Transfection Reagents, Viral Transduction Enhancers, and Other Transfection Reagents), End User (Contract Research Organizations, Pharmaceutical and Biopharmaceutical Companies, and Academic and Research Institutes), and Country
US$ 3,450.00
According to our new research study on “Asia Pacific Cell And Gene Therapy Market Forecast to 2031 –Regional Analysis – by Type, Service, Scale, Service Providers, Transfection Reagents, and End User,...
December 2025
229 pages
Recombinant Albumin Market Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Source (Human Recombinant Albumin, Bovine Recombinant Albumin, and Others), Application (Excipient in Biotherapeutics And Vaccines, Cell Culture, Drug Delivery, Diagnostics, and Others), and End User (Pharmaceutical and Biotechnology Companies, Research Institutes, Hospitals and Diagnostic Laboratories, and Others)
US$ 4,450.00
According to our new research study on “Recombinant Albumin Market Forecast to 2031 –Global Analysis – by Application and End User,” the market is anticipated to grow from US$ 392.50 million in 2024 t...
December 2025
237 pages